ORASURE TECHNOLOGIES, INC Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
ORASURE TECHNOLOGIES, INC (OSUR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 3.40% for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2018-02-28
- ORASURE TECHNOLOGIES, INC effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2017 was 3.40%, a 49.25% decline from fiscal 2016.
- ORASURE TECHNOLOGIES, INC effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2016 was 6.70%, a 17.54% increase from fiscal 2015.
- ORASURE TECHNOLOGIES, INC effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2015 was 5.70%.
- ORASURE TECHNOLOGIES, INC effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2014 was -11.50%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2017-12-31 | 3.40% 10-K · filed 2018-02-28 | |
| 2016-12-31 | 6.70% 10-K · filed 2018-02-28 | |
| 2015-12-31 | 5.70% 10-K · filed 2018-02-28 | |
| 2014-12-31 | -11.50% 10-K · filed 2017-03-14 | 4.00% 10-K · filed 2015-03-12 |
| 2013-12-31 | -0.90% 10-K · filed 2016-03-14 | |
| 2012-12-31 | 1.00% 10-K · filed 2015-03-12 | |
| 2011-12-31 | 5.30% 10-K · filed 2014-03-14 | |
| 2010-12-31 | 6.80% 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |